Shares of Repligen (NASDAQ: RGEN) were up by 14.8% this week as of the market close on Thursday. Repligen announced Q2 revenue of $163 million, up 86% year over year, and well above the consensus Wall Street estimate of $144.1 million. Its base business generated 66% of total revenue, and those sales increased by 35%.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting